trabectedin teva 1 mg prášok na koncentrát na infúzny roztok
teva b.v., holandsko - trabektedín - 44 - cytostatica
trabectedin teva 0,25 mg prášok na koncentrát na infúzny roztok
teva b.v., holandsko - trabektedín - 44 - cytostatica
sertraline zentiva
zentiva k.s., Česká republika - sertralín - 30 - antidepressiva
cyklofosfamid accord 1 000 mg prášok na injekčný/infúzny roztok
accord healthcare polska sp. z o.o., poľsko - cyklofosfamid - 44 - cytostatica
cyklofosfamid accord 500 mg prášok na injekčný/infúzny roztok
accord healthcare polska sp. z o.o., poľsko - cyklofosfamid - 44 - cytostatica
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastické činidlá - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
orserdu
stemline therapeutics b.v. - elacestrant - neoplazmy prsníkov - endokrinná terapia - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
trabectedin ever pharma 1 mg prášok na koncentrát na infúzny roztok
ever valinject gmbh, rakúsko - trabektedín - 44 - cytostatica
trabectedin ever pharma 0,25 mg prášok na koncentrát na infúzny roztok
ever valinject gmbh, rakúsko - trabektedín - 44 - cytostatica
cyklofosfamid accord 2000 mg prášok na injekčný /infúzny roztok
accord healthcare polska sp. z o.o., poľsko - cyklofosfamid - 44 - cytostatica